Xlife Sciences AG (XLS) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.24x

Xlife Sciences AG (XLS) has a Cash Flow Reinvestment Rate of 0.24x as of December 2023, reinvesting CHF41.08K (capex CHF41.08K ) from operating cash flow of CHF171.78K. See Xlife Sciences AG free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.24x

(Capex + Investments) / Operating CF

Total Reinvested

CHF41.08K

Capex + Investments

Operating Cash Flow

CHF171.78K

CHF

Capital Expenditures

CHF41.08K

CHF

Xlife Sciences AG Cash Flow Reinvestment Rate (2023–2023)

Historical reinvestment intensity for Xlife Sciences AG across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Xlife Sciences AG.

Annual Cash Flow Reinvestment Rate for Xlife Sciences AG (2023–2023)

Year-by-year capital reinvestment analysis for Xlife Sciences AG. See XLS financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (CHF)	Operating CF	Capex	YoY Change
2023	6.14x	CHF1.06 Million	CHF171.78K	CHF41.08K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow